Cargando…
Expression of BMP-4 in dentigerous cyst and ameloblastoma: Is it a differentiation measure?
PURPOSE: This study aimed to determine the expression of Bone Morphogenic Protein-4 (BMP-4) in dentigerous cyst (DC), unicystic-ameloblastoma (UA), and Multicysticameloblastoma (MA), and assess whether this marker can be a differentiation measure. MATERIALS AND METHODS: This study included 30 DC, 30...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Istanbul University Faculty of Dentistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012220/ https://www.ncbi.nlm.nih.gov/pubmed/35478708 http://dx.doi.org/10.26650/eor.2022903844 |
_version_ | 1784687750635585536 |
---|---|
author | Sargolzaei, Soudabeh Maleki, Dina Zohary, Maryam |
author_facet | Sargolzaei, Soudabeh Maleki, Dina Zohary, Maryam |
author_sort | Sargolzaei, Soudabeh |
collection | PubMed |
description | PURPOSE: This study aimed to determine the expression of Bone Morphogenic Protein-4 (BMP-4) in dentigerous cyst (DC), unicystic-ameloblastoma (UA), and Multicysticameloblastoma (MA), and assess whether this marker can be a differentiation measure. MATERIALS AND METHODS: This study included 30 DC, 30 UA, and 30 MA blocks if the histopathologic diagnosis of the lesion was definitive, the clinical information and medical records were complete, and the microscopic slides and the paraffin block were available. Age, gender, and location of the lesion were recorded. The samples were analyzed after the immunohistochemical staining (Envision technique). BMP-4 marker was evaluated and reported using Intensity Score (IS), Proportional Score (PS), and Total score (TS). The data were analyzed using SPSS version 21.0. Kruskal-Wallis and Mann-Whitney U tests were applied at the significance level of 0.05. RESULTS: In this study, DCs, UA, and MA had a significant tendency to occur in males compared to females (p<0.001, p<0.001, and p<0.001 respectively), and in the mandible compared to the maxilla (p=0.02, p=0.024, and p=0.02 respectively). The epithelial IS was significantly different among three lesions (p<0.001). IS was higher in MA than UA and DC (p<0.001 and p=0.006, respectively). The IS was not significantly different among the three lesions in connective tissue and around micro-vessels (p=0.3 and p=0.26 respectively). The PS in the epithelium and connective tissue of DC, UA, and MA had no statistical difference (p=0.549 and p=0.540 respectively). The epithelial TS was statistically different among DC, UA, and MA (p<0.001). The TS was higher in UA than MA and DC (p=0.004 and p<0.001 respectively). CONCLUSION: The expression of BMP-4 in the epithelium was higher in ameloblastoma compared to DCs. BMP-4 is a potential measure to differentiate different types of ameloblastoma and dentigerous cyst. The differentiation of these lesions is important as the right treatment plan changes according to the diagnosis. |
format | Online Article Text |
id | pubmed-9012220 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Istanbul University Faculty of Dentistry |
record_format | MEDLINE/PubMed |
spelling | pubmed-90122202022-04-26 Expression of BMP-4 in dentigerous cyst and ameloblastoma: Is it a differentiation measure? Sargolzaei, Soudabeh Maleki, Dina Zohary, Maryam Eur Oral Res Articles PURPOSE: This study aimed to determine the expression of Bone Morphogenic Protein-4 (BMP-4) in dentigerous cyst (DC), unicystic-ameloblastoma (UA), and Multicysticameloblastoma (MA), and assess whether this marker can be a differentiation measure. MATERIALS AND METHODS: This study included 30 DC, 30 UA, and 30 MA blocks if the histopathologic diagnosis of the lesion was definitive, the clinical information and medical records were complete, and the microscopic slides and the paraffin block were available. Age, gender, and location of the lesion were recorded. The samples were analyzed after the immunohistochemical staining (Envision technique). BMP-4 marker was evaluated and reported using Intensity Score (IS), Proportional Score (PS), and Total score (TS). The data were analyzed using SPSS version 21.0. Kruskal-Wallis and Mann-Whitney U tests were applied at the significance level of 0.05. RESULTS: In this study, DCs, UA, and MA had a significant tendency to occur in males compared to females (p<0.001, p<0.001, and p<0.001 respectively), and in the mandible compared to the maxilla (p=0.02, p=0.024, and p=0.02 respectively). The epithelial IS was significantly different among three lesions (p<0.001). IS was higher in MA than UA and DC (p<0.001 and p=0.006, respectively). The IS was not significantly different among the three lesions in connective tissue and around micro-vessels (p=0.3 and p=0.26 respectively). The PS in the epithelium and connective tissue of DC, UA, and MA had no statistical difference (p=0.549 and p=0.540 respectively). The epithelial TS was statistically different among DC, UA, and MA (p<0.001). The TS was higher in UA than MA and DC (p=0.004 and p<0.001 respectively). CONCLUSION: The expression of BMP-4 in the epithelium was higher in ameloblastoma compared to DCs. BMP-4 is a potential measure to differentiate different types of ameloblastoma and dentigerous cyst. The differentiation of these lesions is important as the right treatment plan changes according to the diagnosis. Istanbul University Faculty of Dentistry 2022-01-01 2022-01-01 /pmc/articles/PMC9012220/ /pubmed/35478708 http://dx.doi.org/10.26650/eor.2022903844 Text en Copyright © 2021 European Oral Research https://creativecommons.org/licenses/by-nc-nd/4.0/This article is licensed under Creative Commons License Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license ( (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the journal endorses its use. The material cannot be used for commercial purposes. If the user remixes, transforms, or builds upon the material, he/she may not distribute the modified material. No warranties are given. The license may not give the user all of the permissions necessary for his/her intended use. For example, other rights such as publicity, privacy, or moral rights may limit how the material can be used. |
spellingShingle | Articles Sargolzaei, Soudabeh Maleki, Dina Zohary, Maryam Expression of BMP-4 in dentigerous cyst and ameloblastoma: Is it a differentiation measure? |
title | Expression of BMP-4 in dentigerous cyst and ameloblastoma:
Is it a differentiation measure? |
title_full | Expression of BMP-4 in dentigerous cyst and ameloblastoma:
Is it a differentiation measure? |
title_fullStr | Expression of BMP-4 in dentigerous cyst and ameloblastoma:
Is it a differentiation measure? |
title_full_unstemmed | Expression of BMP-4 in dentigerous cyst and ameloblastoma:
Is it a differentiation measure? |
title_short | Expression of BMP-4 in dentigerous cyst and ameloblastoma:
Is it a differentiation measure? |
title_sort | expression of bmp-4 in dentigerous cyst and ameloblastoma:
is it a differentiation measure? |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012220/ https://www.ncbi.nlm.nih.gov/pubmed/35478708 http://dx.doi.org/10.26650/eor.2022903844 |
work_keys_str_mv | AT sargolzaeisoudabeh expressionofbmp4indentigerouscystandameloblastomaisitadifferentiationmeasure AT malekidina expressionofbmp4indentigerouscystandameloblastomaisitadifferentiationmeasure AT zoharymaryam expressionofbmp4indentigerouscystandameloblastomaisitadifferentiationmeasure |